![]()
Phenotype Annotations Click to see Annotation Detail View
Mammalian PhenotypeTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | decreased heart rate | | IMP | cholinergic antagonist | 13825242 | compared with WI-MC4r^m1Hubr | RGD | | decreased heart rate | | IMP | | 13825242 | | RGD | | decreased locomotor activity | | IMP | | 6478803 | | RGD | | decreased mean systemic arterial blood pressure | | IMP | mecamylamine | 13825242 | | RGD | | decreased vasoconstriction | | IMP | phenylephrine | 13825242 | | RGD | | increased body length | | IMP | | 6478803 | | RGD | | increased body weight | | IMP | | 13825242; 6478803 | | RGD | | increased circulating cholesterol level | | IMP | | 13825242 | | RGD | | increased circulating free fatty acids level | | IMP | | 13825242 | | RGD | | increased circulating insulin level | | IMP | | 13825242 | | RGD | | increased circulating leptin level | | IMP | | 13825242; 6478803 | | RGD | | increased circulating triglyceride level | | IMP | | 13825242 | | RGD | | increased defecation amount | | IMP | | 6478803 | | RGD | | increased fat cell size | | IMP | | 6478803 | | RGD | | increased fluid intake | | IMP | | 13825242; 6478803 | | RGD | | increased glycosylated hemoglobin level | | IMP | | 13825242 | | RGD | | increased heart weight | | IMP | | 13825242 | | RGD | | increased kidney weight | | IMP | | 13825242 | | RGD | | increased subcutaneous adipose tissue amount | | IMP | | 6478803 | | RGD | | increased systemic vascular resistance | | IMP | | 13825242 | | RGD | | increased vasoconstriction | | IMP | potassium chloride solution | 13825242 | | RGD | | increased white adipose tissue amount | | IMP | | 6478803 | | RGD | | obese | | IMP | | 13825198 | | RGD | | polyphagia | | IMP | | 13825242; 6478803 | | RGD | | polyuria | | IMP | | 13825242 | | RGD | | |